BIO-TECHNE Corp
Held by 15 tracked managers as of Q2 2026 · CUSIP ⓘCUSIP: A 9-character ID for one specific security - one share class of one company, or one bond. Tickers can change and can mean different things in different countries; a CUSIP always identifies exactly the same security, which is why filings use it. Guide 09073M104 · Sector ⓘGICS sectors: The 11-sector system most investors know (Global Industry Classification Standard): Technology, Health Care, Financials and so on. This site assigns each company a GICS-style sector from its SIC code, with a few hand corrections, so sector pages match the names investors expect. Guide
In plain English: 15 of the investors we track own this stock. In the latest quarter, 9 of them bought more of it and 7 sold some or all of theirs (5 bought it for the first time). That tells you what they did last quarter — not what the stock will do next.
Educational and informational only, not personalized investment advice. Based on public filings that may be delayed or contain errors; verify with the original filings. Disclaimer
Managers holding
15
+3 vs last quarter (like-for-like)
Total value held
$692.32M
Across tracked managers
Average weight ⓘOn average, how big this stock is in the portfolios that own it (its share of each manager's reported portfolio value).
0.4%
Of each manager's book
QoQ value ⓘLike-for-like: only managers that filed both quarters are compared, so a manager filing late (or confidentially) does not look like buying or selling. Includes price changes.
+$39.65M
+7.2% vs last quarter
Net shares bought
-2.2M
Est. net flow -$136.40M
Quarter activity
9 bought · 7 sold
5 new · 2 sold out
Tracked capital in this stock
Total value held (area) and number of managers (line). Dips can mean a large holder filed that quarter confidentially (e.g. Norges Bank in Q1/Q3).
Aggregate buying and selling
Net share change reported each quarter
Who owns TECH?
🔒 The 'who added and who trimmed' chart is a Plus feature
You're viewing the Free plan. Upgrade to unlock The 'who added and who trimmed' chart — every paid plan starts with a 7-day free trial, and you can cancel in two clicks.
Who owns TECH? — Q2 2026
Holders ranked by position size, with each one's quarter-over-quarter change.
Column filters
| # | Manager ↓ | Fund | Shares | Value | % of their portfolio | QoQ | Δ shares | Δ shares % | Est. Δ value ⓘChange in shares × this quarter's price |
|---|---|---|---|---|---|---|---|---|---|
| 11 | Two Sigma | Two Sigma Investments | 69.62K | $4.92M | 0.0% | Added | +3.5K | +5.3% | +$249.04K |
| 1 | Ruane Cunniff & Goldfarb | Sequoia Fund adviser | 3.35M | $236.60M | 3.7% | Reduced | -43.2K | -1.3% | -$3.05M |
| 15 | Ron Baron | Baron Capital (BAMCO) | 1.80K | $127.17K | 0.0% | Reduced | -559.6K | -99.7% | -$39.54M |
| 13 | Ray Dalio | Bridgewater Associates | 26.75K | $1.89M | 0.0% | Added | +20.8K | +347.5% | +$1.47M |
| 2 | Norges Bank | Norges Bank Investment Management | 1.41M | $99.87M | 0.0% | — | — | — | — |
| 14 | Mario Gabelli | GAMCO Investors | 6.25K | $441.56K | 0.0% | New | +6.2K | — | +$441.56K |
| 12 | Larry Robbins | Glenview Capital | 58.32K | $4.12M | 0.1% | Reduced | -128.0K | -68.7% | -$9.04M |
| 4 | Ken Griffin | Citadel Advisors | 965.92K | $68.24M | 0.0% | Added | +922.5K | +2125.5% | +$65.18M |
| 3 | Israel Englander | Millennium Management | 989.03K | $69.88M | 0.0% | New | +989.0K | — | +$69.88M |
| 8 | Henry Ellenbogen | Durable Capital Partners | 501.96K | $35.46M | 0.3% | Reduced | -4.0M | -88.7% | -$279.35M |
| 7 | George Soros | Soros Fund Management | 535.40K | $37.83M | 0.5% | New | +535.4K | — | +$37.83M |
| 10 | Fred Alger | Fred Alger Management | 101.61K | $7.18M | 0.0% | Reduced | -378 | -0.4% | -$26.71K |
| 9 | David Shaw | D.E. Shaw & Co. | 228.48K | $16.14M | 0.0% | New | +228.5K | — | +$16.14M |
| 6 | Cliff Asness | AQR Capital Management | 761.87K | $53.83M | 0.8% | New | +761.9K | — | +$53.83M |
| 5 | Chuck Royce | Royce & Associates | 789.75K | $55.80M | 0.4% | Added | +30.0K | +4.0% | +$2.12M |
Column filters
| Manager | Fund | Shares sold | Value last quarter ↓ |
|---|---|---|---|
| Select Equity Group | Select Equity Group | -709.8K | $37.10M |
| Steve Cohen | Point72 Asset Management | -295.0K | $15.41M |
Politician trades
Column filters
| Politician | Date | Ticker | Asset | Type | Reported range ⓘThe dollar range the politician reported. Exact amounts are not disclosed. | Est. size ⓘOur estimate only: the midpoint of the reported range. | Owner | Account ⓘSubholding Of: the account the trade was in, as named on the report (e.g. an IRA or a brokerage account). The same stock bought on the same day in different accounts is a separate trade in each account. | Filed ↓ | Filing delay ⓘDays between the trade and the report. Over 45 days is late under the STOCK Act. | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ro Khanna Politician | Jun 2, 2026 | TECH | BIO-TECHNE CORPORATION CMN scanned | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Jul 6, 2026 | 34 days | PTR ↗ |
| Ro Khanna Politician | May 30, 2026 | TECH | BIO-TECHNE CORPORATION CMN scanned | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Jul 6, 2026 | 37 days | PTR ↗ |
| Ro Khanna Politician | May 15, 2026 | TECH | BIO-TECHNE CORPORATION CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Jun 9, 2026 | 25 days | PTR ↗ |
| April McClain Delaney Politician | Apr 8, 2026 | TECH | Bio-Techne Corp - Common Stock (TECH) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Child | — | May 6, 2026 | 28 days | PTR ↗ |
| April McClain Delaney Politician | Mar 26, 2026 | TECH | Bio-Techne Corp - Common Stock (TECH) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Child | — | Apr 6, 2026 | 11 days | PTR ↗ |
| April McClain Delaney Politician | Feb 24, 2026 | TECH | Bio-Techne Corp - Common Stock (TECH) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Child | — | Mar 10, 2026 | 14 days | PTR ↗ |
| Ro Khanna Politician | Jan 29, 2026 | TECH | BIO-TECHNE CORPORATION CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Feb 6, 2026 | 8 days | PTR ↗ |
| April McClain Delaney Politician | Jan 28, 2026 | TECH | Bio-Techne Corp - Common Stock (TECH) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Child | — | Feb 2, 2026 | 5 days | PTR ↗ |
| April McClain Delaney Politician | Dec 2, 2025 | TECH | Bio-Techne Corp - Common Stock (TECH) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Child | — | Jan 5, 2026 | 34 days | PTR ↗ |
| April McClain Delaney Politician | Dec 5, 2025 | TECH | Bio-Techne Corp - Common Stock (TECH) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Child | — | Jan 5, 2026 | 31 days | PTR ↗ |
| April McClain Delaney Politician | Oct 22, 2025 | TECH | Bio-Techne Corp - Common Stock (TECH) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Child | — | Nov 4, 2025 | 13 days | PTR ↗ |
| April McClain Delaney Politician | Aug 1, 2025 | TECH | Bio-Techne Corp - Common Stock (TECH) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Child | — | Sep 2, 2025 | 32 days | PTR ↗ |
| April McClain Delaney Politician | May 26, 2025 | TECH | Bio-Techne Corp - Common Stock (TECH) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Child | — | Jul 2, 2025 | 37 days | PTR ↗ |
| Ro Khanna Politician | May 28, 2025 | TECH | BIO-TECHNE CORPORATION CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Jun 10, 2025 | 13 days | PTR ↗ |
| Julie Johnson Politician | Apr 1, 2025 | TECH | Bio-Techne Corp - Common Stock (TECH) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Joint | Merrill Lynch Tax Efficient Core | May 14, 2025 | 43 days | PTR ↗ |
| Robert P. Bresnahan, Jr. Politician | Apr 8, 2025 | TECH | Bio-Techne Corp - Common Stock (TECH) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | JP Morgan Brokerage Account | May 8, 2025 | 30 days | PTR ↗ |
| April McClain Delaney Politician | Apr 9, 2025 | TECH | Bio-Techne Corp - Common Stock (TECH) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Child | — | May 2, 2025 | 23 days | PTR ↗ |
| April McClain Delaney Politician | Apr 29, 2025 | TECH | Bio-Techne Corp - Common Stock (TECH) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Child | — | May 2, 2025 | 3 days | PTR ↗ |
| Robert P. Bresnahan, Jr. Politician | Feb 25, 2025 | TECH | Bio-Techne Corp - Common Stock (TECH) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | JP Morgan Brokerage Account | Mar 27, 2025 | 30 days | PTR ↗ |
| Ro Khanna Politician | Feb 25, 2025 | TECH | BIO-TECHNE CORPORATION CMN scanned | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Mar 6, 2025 | 9 days | PTR ↗ |
| Ro Khanna Politician | Feb 19, 2025 | TECH | BIO-TECHNE CORPORATION CMN scanned | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Mar 6, 2025 | 15 days | PTR ↗ |
| Ro Khanna Politician | Dec 16, 2024 | TECH | BIO-TECHNE CORPORATION CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Jan 8, 2025 | 23 days | PTR ↗ |
| Ro Khanna Politician | Oct 14, 2024 | TECH | BIO-TECHNE CORPORATION CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Nov 8, 2024 | 25 days | PTR ↗ |
| Ro Khanna Politician | Jul 1, 2024 | TECH | BIO-TECHNE CORPORATION CMN scanned | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Aug 7, 2024 | 37 days | PTR ↗ |